Using laser-Doppler flowmetry during ventric ulocisternal perfusion with inulin-[1 4 C]carboxylic acid,
demonstrating that CSF production and blood flow are not directly coupled in the choroid plexus. When infused intravenously, VIP (10 or 100 pmol/kg/min) increased CPBF, an effect partly antagonized at higher concentra tions owing to a VIP-induced systemic hypotension. No effect of VIP on CSF production could be seen with in travenous administration. Key Words: Cerebrospinal fluid-Choroid plexus blood flow-Laser-Doppler flow metry-Vasoactive intestinal polypeptide-Ventriculo cisternal perfusion.
Autonomic nerve fibers in the choroid plexus contain several peptide transmitters in addition to the classic transmitters noradrenaline (Lindvall et aI., 1978a) and acetylcholine (Lindvall et aI., 1977) .
Evidence points to two main autonomic nerve in puts to the choroid plexus: (a) a sympathetic inner vation containing noradrenaline and neuropeptide Y (NPY) and (b) nerve fibers containing vasoactive intestinal polypeptide (VIP), peptide histidine iso leucine (PHI), and NPY (Nilsson et a!., 1990a) probably identical with the cholinergic nerves pre viously demonstrated (Lindvall et aI., 1977) . The role of these peptide cotransmitters in the choroid plexus is largely unknown. There is evidence that NPY inhibits, while VIP and PHI stimulate, eH]noradrenaline release from sympathetic fibers in the choroid plexus during electrical nerve stimu lation (Nilsson et aI., 1990b) . Furthermore, there are VIP receptors on the secretory epithelial cells of the choroid plexus (Nilsson et aI., 1991) coupled to a stimulation of cyclic AMP production in cultured epithelial cells and whole rabbit choroid plexus (Lindvall et aI., 1985; Crook and Pruisner, 1986) .
VIP also dilates the bovine anterior choroidal artery in vitro (Lindvall et aI., 1978b) .
In this study we have investigated the effect of VIP on choroid plexus blood flow (CPBF) and CSF production measured simultaneously in rats, using laser-Doppler flowmetry during ventriculocisternal perfusion with e4 C]inulin.
MATERIALS AND METHODS

Animals
Forty-five male Sprague-Dawley rats, weighing 280--430 g, were used in the experiments. The animals were held under a regimen of 12 h lightll2 h darkness and were given pellet food and tap water ad lib. The experiments were approved by the local Animal Ethics Committee.
Ventriculocisternal perfusions
To measure CSF production, the ventriculocisternal perfusion method originally described by Pappenheimer et al. (1962) for use in goats was modified for use in rats. The protocol closely followed that previously developed in this laboratory for rabbits (Aquilonius and Winbladh, 1972; Lindvall et aI., 1979) . The animal was anesthetized with 1.5% halothane in 02/N20 (0.6 and 1.3 Limin, re spectively). It was placed on a heating pad, and the two femoral arteries and one or both femoral veins were cath eterized for blood pressure recording, blood sampling, drug administration, and peptide infusion. Subsequently, the animal was trachetomized and put on artificial venti lation with 1 % halothane in humified O2 and N20 as above. Alcuronium (Alloferin; Roche, Switzerland) was used as muscle relaxant: 0.05 mg was given initially fol lowed by 0.02 mg every 20--30 min. The wounds were treated with xylocaine-soaked gauze and closed. The an imal was then placed in a stereotaxic frame and the skin on the scalp was incised in the midline. Two holes were drilled in the skull above each lateral ventricle, 0.8 mm caudal and 1.4 mm lateral to bregma (Paxinos and Wat son, 1986) . The laser-Doppler probe and the inflow can nula, both with an OD of 0.45 mm, were placed above each of the two holes. The skin and muscles overlying the atiantooccipital membrane were separated and the liga ment exposed. The inflow cannula was lowered 3.3 mm into the right lateral ventricle and the connected pump (Vnita II; Braun Melsungen AG, F.R.G.) started to give a rate of 14 J.1l1min. A 27G needle, connected by tubing to a peristaltic pump (Harvard Instruments), was used to puncture the atlantooccipital membrane and carefully in serted into the cisterna magna, whereafter the pump was started to give the same rate as above. The halothane concentration was gradually decreased during the opera tions to 1.0%, which was then maintained throughout the experiment. The ventricular system was perfused with mock CSF of the following composition (mM): NaC1123, CaCl2 0.86, KCI 3.0, MgCl2 0.89, NaHC03 25, NaH2P0 4 0.50, Na2HP0 4 0.25, pH 7.3, containing 1 mg/IOO ml in ulin-[14C]carboxylic acid, 9.8 mCi/mmol (Amersham), and pregassed with 5% CO2 and 2.5% O2, The tempera ture of the animal was measured with a rectal probe con nected to a digital thermometer and kept between 37.0 and 37.soC with the aid of a heating pad and a lamp. Blood pressure and perfusion pressure were continuously re corded on a Grass model 7 polygraph. Blood samples were taken at least every 30 min to analyze arterial Pc02, Vol. 11, No. 5, 1991 P02, and pH, and the ventilation volume and rate were changed if necessary to keep these parameters within a physiological range. Following a 1.5-h control period, the perfusion solution was changed either to a new control solution (i.e., artificial CSF and [1 4 Clinulin without addi tion of peptide) or artificial CSF containing VIP (10 -9 or 10-7 M). Alternatively, VIP was infused through the fem oral vein at a dose of 10 or 100 pmollkg/min. CSF pro duction was calculated from the mean radioactivity ob tained in six 5-min samples of the outflow and inflow perfusion fluid, respectively, according to Heisey et al. (1962) : Vf = Vp(Ci -Col/Co, where Vf is the CSF pro duction rate, V p the perfusion rate, and Ci and Co the radioactivity in the inflow and outflow perfusion fluid, respectively. At the end of each experiment, the animal was killed with an overdose of sodium pentobarbital (Mebumal; Aco, Sweden). In separate control experi ments (n = 3), rats were perfused with artificial CSF containing the dye toludine blue, followed by decapita tion and examination of the brain cut in slices. Strong staining could be seen along the perfusion pathway, i.e., right lateral ventricle, third ventricle, cerebral aqueduct, and fourth ventricle, while staining was weaker in the left ventricle. No staining was found in the brain parenchyma or elsewhere outside the ventricular system, except for very weak staining in the part of the subarachnoid space surrounding the optic chiasm.
Laser-Doppler flowmetry
Laser-Doppler flowmetry was used to measure CPBF (Stern et aI., 1977; Nilsson et aI., 1980) with a Periflux PF2B laser-Doppler equipment (Perimeter, Sweden) hav ing a built-in linearizer for high-flow perfusion areas (Nilsson, 1984) . A laser-Doppler probe with an OD of 0.45 mm was placed on the surface of the brain as de scribed above and the cortical blood flow registered for 5 min. Thereafter the probe was lowered stereotaxically into the brain tissue to a depth of 3.0--3.5 mm, i.e., the location of the lateral ventricles and the lateral choroid plexus. CPBF was defined by measurement of a narrow region of high blood flow (50--300% of that of the cortical surface) surrounded by regions with no or very low blood flow, corresponding to the surrounding CSF. The probe was then kept in the same position for the rest of the experiment. In three separate experiments, in rats weigh ing 380--420 g, CPBF was measured during systemic hy potension induced by withdrawal of 3.5 ml arterial blood. V sing the corresponding values of mean arterial blood pressure (mm Hg) and CPBF (arbitrary units), the relative vascular resistance (mm Hg/arbitrary unit) was calculated before and during systemic hypotension, as well as during the first and second perfusion periods in all other exper iments.
Statistics
Heterogeneity between the means in each group was assessed by one-way analysis of variance, while possible differences in standard deviation between experimental groups were investigated by the F test (Wardlaw, 1985) . The individual absolute values for CSF production and CPBF during the second perfusion period were evaluated statistically in comparison with the respective values dur ing the first perfusion period (control) for each animal using the Student t test based on paired observations. Changes in CSF production and CPBF were expressed as the ratio between the values obtained from the second and first perfusion period, respectively.
RESULTS
The control parameters during control perfusions and administration of peptides are summarized in Table 1 . No changes in arterial PeoZ, Po2, pH, or blood pressure could be seen during control exper iments or with intraventricular administration of VIP, except a slight increase in Peo2 with time, which, however, remained within a physiological range (Table 1 ). In control experiments, CSF pro duction and CPBF did not change appreciably. The mean CSF production rate during the initial control perfusion was 2.2 ± 0.6 fLl/min (average ± SD; n = 32), while CPBF on average was 115 ± 68% (aver age ± SD; n = 32) of cortical surface blood flow (CBF), the ratio CPBF/CBF having a range of �0.5-3. VIP lowered CSF production by 27 and 20% at 10-7 and 10-9 M, respectively ( Fig. 1) . In contrast, an increase in CPBF was seen, 20% higher than control values (Fig. 1) . The increase in CPBF dur ing perfusion with VIP showed slightly different characteristics in different experiments varying from transient, 10-to 20-min long increases at the start of the perfusion to more long-lasting, some times delayed, increases. Intravenous infusion of VIP at a dose of 100 pmollkg/min induced a de crease in blood pressure (Table 1) by 30%, without affecting CPBF, while VIP at 10 pmol/kg/min in creased CPBF by 20% without altering the blood pressure (Fig. 2) . The CSF production did not change during intravenous administration of VIP ( Fig. 2) .
Vascular resistance decreased during oligemic hypotension and showed a clear tendency to de crease during VIP-induced systemic hypotension, although the change was not statistically significant (Table 2 ). The decrease in vascular resistance was greater than when VIP was given at a lower dose intravenously or administered intraventricularly (data not shown). The statistical analysis described above validated the use of the Student t test for evaluating possible changes induced by VIP.
DISCUSSION
The ventriculocisternal perfusion method, origi nally developed by Pappenheimer et al. (1962) , is well established for measuring CSF production rates (Pappenheimer et aI., 1962; Heisey et aI., 1962; Johanson and Woodbury, 1974; Haywood and Vogh, 1979; Lindvall et aI., 1979) . Although the method was initially designed for goats, it has been successfully adapted to frogs (Taylor and Jones, 1985) , rabbits (Lindvall et aI., 1979; Faraci et aI., 1988) , cats (Haywood and Vogh, 1979) , and rats (Cserr, 1965; Johanson and Woodbury, 1974; Har nish and Samuel, 1988) .
Halothane has been reported to decrease CSF production at concentrations similar to those pres ently used (Artru, 1983; Artru and Hornbein, 1986) .
In spite of this, presently obtained CSF production values were similar to values previously reported using other anesthetics. A significant decrease in CSF production could be seen during intraventric ular administration of VIP at a concentration of both 10-9 and 10-7 M.
Although several sources of CSF production have been suggested, there is strong evidence that the choroid plexus produces some 80% of it (Pollay et aI., 1985; Davson et aI., 1987) . VIP stimulates cyclic AMP production in choroid plexus epithe lium (Crook and Pruisner, 1986) , presumably by ac tivating specific VIP receptors present on the cells (Nilsson et aI., 1991) . Similarly, noradrenaline stim ulates cyclic AMP production via an effect on �-receptors in the choroid plexus epithelial cells (Nathanson, 1979; Lindvall et aI., 1985) and de creases CSF production (Lindvall et aI., 1979) .
Thus, it is possible that VIP can inhibit CSF pro duction by increasing the intracellular concentra tion of cyclic AMP in the choroid plexus epithelium (Nilsson et aI. , 1990b) . A combined, synergis tic action cannot be ruled out either, similar to the synergistic action of VIP on phenylephrine mediated responses seen in rat salivary glands (Bobyock and Chernick, 1989) .
A decrease in the CSF production could be seen both at 10-9 and 10-7 M concentrations of VIP.
The estimated Kd value for the VIP receptor is 3. 2 nM (Nilsson et aI. , 1991) . As the concentration of VIP in human CSF is only 50 pM (Fahrenkrug et al. , 1977) , it seems unlikely that VIP diffusely released into the CSF could affect CSF production. It is more likely that the observed effect is mediated by VIP released locally from the VIP-immunoreactive nerves present in the choroid plexus (Lindvall et aI. , 1978b; Nilsson et aI. , 1990a) . However, it can not be excluded that the concentration of VIP is higher in rat CSF or that VIP might be released into the CSF in larger amounts in certain physiological situations. The lack of effect on CSF production when VIP was given intravenously might support an apical location of VIP receptors, which cannot be reached by VIP given on the blood side of the blood-CSF barrier. On the other hand, it is also possible that the short half-life (1-2 min) of VIP in blood and degradation in the choroid plexus con nective tissue prevent sufficient concentrations be ing reached at the VIP receptors in the choroid plexus epithelium.
Aqueous humor in the eye is produced by the ciliary body by a process that resembles the pro duction of CSF. In contrast to the effect on CSF production in rat, VIP has been reported to in- crease aqueous humor flow in rabbit and monkey (Nilsson et aI. , 1986; Moolchandani and Krupin, 1987) . On the other hand, adenylate cyclase activa tion reduces net aqueous flow in several species, including humans (Sears, 1985) .
In vivo measurements of CPBF have utilized ei ther the radioactive microsphere technique (Page et aI., 1980; Faraci et aI., 1988; Maktabi et aI., 1990) or the e4C]iodoantipyrine method (Tyson et aI. , 1982; Tuor et aI., 1988) . Both are well established meth odologically for quantification of tissue blood flow.
Their main disadvantage is that they do not provide continuous blood flow measurements, making it im possible to study dynamic changes. Laser-Doppler flowmetry is based on the detection and analysis of laser light that has been reflected and Doppler shifted by the red blood cells perfusing the tissue (Nilsson et aI., 1980; Tenland, 1982) . The method shows linear correlation with other means of mea suring blood flow, including hydrogen clearance, radioactive microspheres, 133Xe clearance, as well as recording pial arteriolar diameter (K vietys et aI. , 1985; Eyre et aI., 1988; Skarphedinsson et aI., 1988; Haberl et aI., 1989a; Monteiro et aI. , 1989) . It has been used to register blood flow changes in many different tissues, including the brain (Williams et aI., 1980; Johansson et aI., 1987; Haberl et aI. , 1989b; Suzuki et aI., 1990) . Although the original standard probes allow for measurements only in skin or at the surface of organs, the development of needle probes (00 0.45 mm) makes it possible to record deep tissue perfusion as well (Salerud and Oberg, 1987) .
In the present study, we used a needle probe stereotaxically placed in the lateral ventricle to measure CPBF. The penetration depth of the laser light is not exactly known, but has been estimated to be <1 mm in skin (Tenland, 1982) , although this view has been contested by others (K vietys et aI., 1985; Johansson et aI., 1987) . However, the laser light might penetrate less in tissues with high blood flow, such as the choroid plexus, owing to the re flection of most of the light by the superficially 10-cated red blood cells. The high blood flow of the choroid plexus is comparable with that of the kid ney (Maktabi et aI. , 1990) and could be identified as a sharply delineated area of high blood flow sur rounded by areas with little or no flow, probably corresponding to the CSF of the lateral ventricles.
This makes it likely that we are measuring CPBF.
Comparison of CPBF with cortical surface blood flow showed considerable variation, probably be cause the choroid plexus is not fixed, but rather a villous, membrane-like structure with a narrow at tachment at its base. With the present approach it is therefore not possible to position the probe in rela tion to the choroid plexus in exactly the same way in each experiment. Previous assessments report ei ther similar or higher blood flow in the choroid plexus compared with that of the cortical surface (Faraci et aI. , 1988; Tuor et aI., 1988) .
The cerebral vessels are richly innervated by VIP-immunoreactive nerve fibers (Suzuki et aI., 1988) , which have a vasodilative role (Suzuki et aI., 1984) . Also the arteries and arterioles in the choroid plexus are innervated by VIP fibers (Lindvall et aI. , 1978b; Nilsson et aI. , 1990a) , and VIP induces re laxation of the anterior chorodial artery in vitro (Lindvall et aI. , 1978b) . In the present study, we demonstrate that VIP increases blood flow in the choroid plexus significantly at low concentrations during ventriculocisternal perfusion with the pep tide. An increase in CPBF could also be seen during intravenous infusion with 10 pmol/kg/min VIP, while no change was seen at higher concentrations (100 pmol/kg/min), probably because VIP induces systemic hypotension when administered intrave nously at moderate or high doses in rats and hu mans (Bouder et aI. , 1988; Smitherman et aI., 1989; Koyama et aI. , 1990) . The hypotension, with the resulting decrease in vascular resistance, might counteract any VIP-induced increase in CPBF, as has been shown for the CBF during oligemic hy potension (Gygax and Wiernsperger, 1982) .
In conclusion, VIP might have a regulatory role in the choroid plexus, modulating the CSF produc-tion and blood flow of this tissue. The observation that VIP decreases the CSF production while it in creases CPBF strongly indicates that these two pa rameters may not be directly coupled. This was re cently shown with acetazolamide as well (Faraci et aI., 1990) .
